Nitric oxide scavenger carboxy-PTIO potentiates the inhibition of dopamine uptake by nitric oxide donors

被引:22
作者
Cao, BJ [1 ]
Reith, MEA [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Biomed & Therapeut Sci, Peoria, IL 61656 USA
关键词
dopamine uptake; nitric oxide (NO) scavenger; carboxy-PTIO (2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide); carboxy-PTI (2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl);
D O I
10.1016/S0014-2999(02)01908-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (carboxy-PTIO) has been increasingly used as nitric oxide (NO) scavenger. Carboxy-PTIO reacts with NO to form nitric dioxide and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl (carboxy-PTI). In rat C6 glioma cells expressing human dopamine transporter, carboxy-PTIO paradoxically potentiated the inhibition of [3 H]dopamine uptake by two NO donors, diethylamine/NO and (Z)-1-[N-(3-ammoniopropyl)-N-(n-propyl)-amino]/NO. Further examinations revealed that carboxy-PTI concentration-dependently reduced dopamine uptake, indicating that the formation of carboxy-PTI may account for the failure of carboxy-PTIO to abolish NO elicited effects. These results suggest that caution should be taken in interpreting data obtained using carboxy-PTIO and probably other NO scavengers. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:27 / 30
页数:4
相关论文
共 19 条
[1]   ANTAGONISTIC ACTION OF IMIDAZOLINEOXYL N-OXIDES AGAINST ENDOTHELIUM-DERIVED RELAXING FACTOR .NO THROUGH A RADICAL REACTION [J].
AKAIKE, T ;
YOSHIDA, M ;
MIYAMOTO, Y ;
SATO, K ;
KOHNO, M ;
SASAMOTO, K ;
MIYAZAKI, K ;
UEDA, S ;
MAEDA, H .
BIOCHEMISTRY, 1993, 32 (03) :827-832
[2]   REACTION BETWEEN IMIDAZOLINEOXIL N-OXIDE (CARBOXY-PTIO) AND NITRIC-OXIDE RELEASED FROM CULTURED ENDOTHELIAL-CELLS - QUANTITATIVE MEASUREMENT OF NITRIC-OXIDE BY ESR SPECTROMETRY [J].
AZMA, T ;
FUJII, K ;
YUGE, O .
LIFE SCIENCES, 1994, 54 (11) :PL185-PL190
[3]  
ESHLEMAN AJ, 1995, J PHARMACOL EXP THER, V274, P276
[4]   The use of nitric oxide donors in pharmacological studies [J].
Feelisch, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) :113-122
[5]   Diazeniumdiolates: Pro- and antioxidant applications of the "NONOates" [J].
Fitzhugh, AL ;
Keefer, LK .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (10) :1463-1469
[6]  
Fumagalli F, 1998, J NEUROSCI, V18, P4861
[7]   REACTIONS OF NITRIC-OXIDE WITH NITRONYL NITROXIDES AND OXYGEN - PREDICTION OF NITRITE AND NITRATE FORMATION BY KINETIC SIMULATION [J].
HOGG, N ;
SINGH, RJ ;
JOSEPH, J ;
NEESE, F ;
KALYANARAMAN, B .
FREE RADICAL RESEARCH, 1995, 22 (01) :47-56
[8]   Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: Implications for the prevention of methamphetamine-induced neurotoxic damage [J].
Imam, SZ ;
Islam, F ;
Itzhak, Y ;
Slikker, W ;
Ali, SF .
NEUROBIOLOGICAL MECHANISMS OF DRUGS OF ABUSE: COCAINE, IBOGAINE, AND SUBSTITUTED AMPHETAMINES, 2000, 914 :157-171
[9]   NITRONYL NITROXIDES AS PROBES TO STUDY THE MECHANISM OF VASODILATORY ACTION OF NITROVASODILATORS, NITRONE SPIN TRAPS, AND NITROXIDES - ROLE OF NITRIC-OXIDE [J].
KONOREV, EA ;
TARPEY, MM ;
JOSEPH, J ;
BAKER, JE ;
KALYANARAMAN, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (02) :169-177
[10]  
LONART G, 1994, J NEUROCHEM, V63, P2108